Biểu đồ giá cổ phiếu OCS
OCS Dự đoán giá cổ phiếu
Oculis Holding AG
$0
0%
$0
Khi đóng cửa: Apr 30, 16:00:00 GMT-4
$0
0%
$0
Phiên sau giờ: Apr 30, 19:00:26 GMT-4
Quay lại
Oculis Holding AG (OCS) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
--
Giá mở cửa
--
Phạm vi ngày
-
Phạm vi 52 tuần
-
Khối lượng
--
Khối lượng trung bình
--
Tỷ suất cổ tức
--
EPS (TTM)
--
Vốn hóa thị trường
--
OCS là gì?
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The company is headquartered in Zug, Zug and currently employs 60 full-time employees. The company went IPO on 2023-03-03. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
